Penumbra Inc

Healthcare · Medical Devices

319.70$ +0.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Penumbra Inc (PEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 390 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PEN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	67	73	73	81	84	96	103	110	112	121	128	134	140	145	137	105	151	167	169	184	190	204	204	208	214	221	241	261	271	285	279	299	301	316	324	339	355	385	375	390	1,505
Cost of Revenue	24	27	26	30	29	32	36	37	37	42	45	40	44	47	49	40	60	73	58	66	70	79	76	74	78	83	90	95	93	98	98	137	101	105	108	115	114	123	121	125	484
Gross Profit	43	47	48	51	55	64	67	72	75	79	84	94	96	98	88	65	91	94	111	119	120	125	127	134	135	138	151	167	178	187	181	163	200	211	216	224	240	262	253	265	1,021
Research & Development	6.5	6.1	7.0	8.1	8.1	8.4	8.0	8.2	9.1	11	12	13	14	13	13	23	35	19	18	18	17	52	21	20	21	18	20	22	21	22	25	25	25	20	22	23	23	22	22	25	92
Selling, General & Administrative	38	41	43	44	46	51	54	55	56	61	61	68	69	75	74	60	76	74	80	91	94	112	111	115	109	115	123	127	123	129	144	142	140	148	153	160	169	181	193	199	741
Total Operating Expenses	44	48	50	52	54	60	63	63	96	72	73	81	83	88	87	83	111	96	98	108	111	166	131	134	130	134	143	149	165	152	169	244	165	168	176	183	192	203	215	224	834
Operating Income	-1.4	-1.2	-2.0	-1.3	0.7	3.9	4.0	9.3	-21	6.7	11	13	13	11	0.6	-18	-20	-1.7	13	10	8.8	-40	-4.0	-0.1	5.4	4.8	8.0	18	13	35	12	-81	35	43	40	41	49	59	38	41	187
Interest Expense	0.6	0.0	0.6	0.6	0.7	0.0	0.7	0.7	0.8	0.0	0.7	0.8	0.8	–	0.3	0.1	0.4	0.4	0.5	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.6	0.4	1.1	3.1	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.3
Pre-Tax Income	-1.1	-1.5	-1.8	-1.1	0.7	3.9	4.5	9.7	-20	7.3	12	14	13	12	-0.7	-17	-20	-0.5	12	10	7.8	-41	-5.1	-1.2	3.0	7.1	8.7	20	13	38	15	-78	40	44	44	45	52	64	42	46	204
Income Tax Expense	0.0	0.9	1.4	0.5	0.5	-5.9	-1.9	-4.9	1.6	0.9	1.5	-2.7	2.0	2.4	-1.6	-4.1	-9.9	-3.1	1.5	1.9	-0.2	-16	-5.2	2.5	5.3	3.3	0.1	0.6	4.1	-16	3.6	-18	10	11	4.6	0.0	6.5	16	9.1	11	43
Net Income	12	15	-3.1	-1.6	0.2	9.1	5.5	13	-19	6.7	11	17	11	9.7	1.4	-12	-8.8	3.6	12	9.2	8.9	-25	0.1	-3.7	-2.3	3.9	8.6	19	9.2	54	11	-60	30	34	39	45	46	47	33	35	161
EBITDA	-0.7	-0.7	-1.4	-0.6	1.8	5.1	5.4	11	11	8.4	13	15	15	13	3.6	-15	-17	1.7	17	14	11	-35	0.7	4.8	9.3	14	15	27	38	32	23	-70	44	49	49	51	55	68	47	52	222

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings